Social Media Ideas for Sandoz

Glenmark launches generic Olanzapine injection in US

Sandoz's Patent Loss Blocks Antitrust Suit, 4th Circ. Told

Retired U.S. Circuit Judge Paul R. Michel is backing Amgen against Sandoz's Fourth Circuit appeal, arguing in an amicus brief that the final say over now-nixed allegations of block...

July 15 2026 - Sun Pharma wins South Africa approval to launch generic Ozempic

July 15 2026 - Sun Pharma wins South Africa approval to launch generic Ozempic admin Wed, 07/15/2026 - 12:37 Innovation remained front and center today, with progre...

<![CDATA[Novartis Announces $105 Million Collaborative Agreement with Antares Therapeutics]]>

Sandeep Singh

Sandeep Singh Anonymous (not verified) Sun, 07/05/2026 - 06:08 field_thread_url https://cafepharma.com/boards/threads/sandeep-singh.714654/...

Sang

Sang Anonymous (not verified) Thu, 06/25/2026 - 03:02 field_thread_url https://cafepharma.com/boards/threads/sang.673523/ board name...

<![CDATA[CVS Restores Coverage of Lilly’s Zepbound, Adds Oral Obesity Drug Foundayo]]>

Dr Reddy’s launches Bosutinib tablets in US market

The company has collaborated with MSN Laboratories on the product

<![CDATA[TrumpRx Expands to Offer Generic Medications]]>

<![CDATA[Pharmaceutical Executive Daily: FDA Approves Subcutaneous Formulation of Leqembi Iqlik]]>

Shantha Biologics to provide cartridge fill-finish services for Novo Nordisk

<![CDATA[Eli Lilly and Novo Nordisk Shift Patients From Compounded Drugs to Lower-Cost Weight-Loss Pills: Report ]]&g...

CVS obesity drug deal puts Lilly on equal footing with Novo

The agreement includes Lilly’s new pill Foundayo and restores coverage for Zepbound, erasing what had been a commercial edge for rival Novo Nordisk. 

Samsung Bioepis launches Ustekinumab biosimilar in Japan with Nipro

Samsung Bioepis announced Wednesday the launch of its Ustekinumab biosimilar in Japan, marking the company’s first product debut in the country under a partnership with NIPRO Corp....

Hanmi Signs Licensing Deal with Lilly for sonefpeglutide (LAPSGLP-2 analog)

Lilly licenses Hanmi's sonefpeglutide (LAPSGLP-2 analog) for multiple indications

<![CDATA[Pharmaceutical Executive Daily: FDA Approves Subcutaneous Sarclisa Escena]]>

Novo Nordisk will slash Ozempic price for some, ‘aligning’ with generics

Ozempic and Wegovy, both produced by Novo Nordisk, currently cost hundreds of dollars a month, depending on the dosage dispensed, in some cases more than $450.

Alkem rolls out single-shot pre-filled syringes of semaglutide

Alkem Laboratories said the one shot pre-filled syringe format expands treatment options for patients and lowers entry barriers by making it affordable

Lower-Cost Generic Ozempic (Semaglutide) Is Now Available From Canada for U.S. Patients

Americans Can Access Affordable Generic Ozempic (Semaglutide) Through Reliable Canadian Prescription Referral Services

Novartis’ strategy in 2026: rebuilding the pipeline after Entresto 

Find out what Novartis' pipeline strategy since it spun off its biosimilars and generics business Sandoz, and engage in intensive dealmaking. The post Novartis’ strategy in 2026: r...

Generic semaglutide to hit Canadian pharmacies this week at lower cost

Health Canada approved both Dr. Reddy's and Apotex's generic semaglutide — the active ingredient in brand-name Ozempic and Wegovy — about three weeks ago.

<![CDATA[Novartis to Acquire Myricx Bio for $1.1 Billion]]>

Flemming’s replacement

Flemming’s replacement Anonymous (not verified) Wed, 06/03/2026 - 14:44 field_thread_url https://cafepharma.com/boards/threads/flemming%E2%80%99s-replaceme...

Granules India gets First-To-File status for generic Lumryz tablets in US

This was Granules’ second Sole First-to-File ANDA, following its earlier approval for Amphetamine Extended-Release Tablets,